Android app Apple app link

Ligand Pharmaceuticals Incorporated (LGND) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$104.49

south_east
-$0.65 (-0.62%)
Day's range
$102.5
Day's range
$107.49

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/21/2024 H.C. Wainwright Joseph Pantginis $157.00 $108.31   44.95%
10/02/2024 Oppenheimer Leland Gershell $135.00 $99.95   35.07%
07/29/2024 RBC Capital Douglas Miehm $130.00 $108.75   19.54%
07/09/2024 Craig-Hallum Matt Hewitt $140.00 $86.88   61.14%
06/28/2024 H.C. Wainwright Joseph Pantginis $144.00 $82.33   74.91%

Ligand Pharmaceuticals Incorporated FAQ's

Ligand Pharmaceuticals Incorporated has been rated by research analysts at UBS, H.C. Wainwright, Oppenheimer, RBC Capital, Craig-Hallum, Roth Capital in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.